ANTIPHONICS IVS: Financial statements 2016
CVR: 35651543
Source: annual report 2016, Danish Business Authority
01/01/2016 – 31/12/2016
ANTIPHONICS IVS (CVR 35651543) has filed annual accounts for 2016. In 2016, the company reported revenue of DKK 45,312 and a net result of DKK 15,968 compared with DKK -5,633 the year before. That is a decrease of 39.7% compared with the year before. The profit margin was 35.2%. Equity in the 2016 report amounted to DKK 40,369. The solvency ratio was 108.3%.
- Revenue
- DKK 45,312
- Gross Profit
- DKK 20,976
- Profit/Loss
- DKK 15,968
- Equity
- DKK 40,369
- Total Assets
- DKK 37,285
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2016 | 45 t. | 21 t. | 16 t. | 40 t. | - |
| 2015 | 75 t. | 22 t. | -6 t. | 63 t. | - |
| 2014 | 34 t. | -39 t. | -57 t. | 57 t. | - |
Official annual report
Find more companies like ANTIPHONICS IVS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2016
ANTIPHONICS IVS has published its annual report for 2015. Revenue came to DKK 75,115, and the net result was DKK -5,633.
About ANTIPHONICS IVS
ANTIPHONICS IVS was a Danish company of the type Iværksætterselskab based in Herlev, founded in 2014. The company has been dissolved on 2 December 2021. The company was registered under the industry Indspilning af lydoptagelser og udgivelse af musik. In 2020, the company reported revenue of DKK 11,726 and a net result of DKK -7,946 compared with DKK -6,694 the year before. Equity in the 2020 report amounted to DKK 122,533.